Submission Details
| 510(k) Number | K191640 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 19, 2019 |
| Decision Date | August 26, 2020 |
| Days to Decision | 434 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K191640 is an FDA 510(k) clearance for the TK Intravascular Administration Set, a Set, Administration, Intravascular (Class II — Special Controls, product code FPA), submitted by Anhui Tiankang Medical Technology Co., Ltd. (Tianchang, CN). The FDA issued a Cleared decision on August 26, 2020, 434 days after receiving the submission on June 19, 2019. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K191640 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 19, 2019 |
| Decision Date | August 26, 2020 |
| Days to Decision | 434 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FPA — Set, Administration, Intravascular |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |